Impact of Predilatation Between Self-expanding Valves

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

July 20, 2022

Conditions
Aortic Stenosis
Interventions
DEVICE

Transcatheter Aortic Valve Implantation with ACURATE NEO/TF

Transcatheter implantation of the heart valve device ACURATE neo/TF in patients suffering from severe aortic stenosis and are candidates for this operation

DEVICE

Transcatheter Aortic Valve Implantation with Medtronic CoreValve /Evolut R/Pro

Transcatheter implantation of the heart valve device Medtronic Evolut R/Pro in patients suffering from severe aortic stenosis and are candidates for this operation

Trial Locations (1)

11527

Hippocration Hospital First Department of Cardiology, University of Athens, Medical School, Athens

All Listed Sponsors
collaborator

Naval Hospital, Athens

OTHER

collaborator

Silesian Centre for Heart Diseases

OTHER

collaborator

University General Hospital of Heraklion

OTHER

collaborator

Interbalkan Medical Center, Thessaloniki, Greece

UNKNOWN

lead

National and Kapodistrian University of Athens

OTHER

NCT04157920 - Impact of Predilatation Between Self-expanding Valves | Biotech Hunter | Biotech Hunter